Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06458257
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-01-09
Brief Title:
The Efficacy of Allogeneic Hematopoietic Stem Cell Transplantation in Newly Diagnosed High-relapse-risk CEBPA Mutant Acute Myeloid Leukemia
Sponsor:
Ruijin Hospital
Organization:
Ruijin Hospital
Organization Data
Organization:
Ruijin Hospital
Class:
OTHER
Study ID:
CEBPA-AML01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Ruijin Hospital
Lead Sponsor Class:
OTHER
Responsible Party:
Shen yang
Responsible Party Title:
Chief physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Ruijin Hospital
Old Name:
None
Old Organization:
None